| abstract |
The present invention relates to bis (sulfonamide) compounds and pharmaceutically acceptable salts thereof. The present invention also provides pharmaceutical compositions comprising these compounds and the treatment and / or treatment of diseases, disorders or conditions where modulation of microsomal prostaglandin E synthase-1 activity is beneficial, such as pain, inflammation and cancer. Or its use as a prophylactic agent. |